Society guideline links: Marfan syndrome

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Aortic dissection and other acute aortic syndromes".)

●(See "Society guideline links: Aortic and other peripheral aneurysms".)

●(See "Society guideline links: Cardiac valve disease".)

●(See "Society guideline links: Management of cardiovascular diseases during pregnancy".)

International

●Revised Ghent nosology for the Marfan syndrome (2010)

Canada

●Canadian Cardiovascular Society (CCS): Position statement on the management of thoracic aortic disease (2014)

United States

●American College of Cardiology (ACC)/American Heart Association (AHA): Guideline for the diagnosis and management of aortic disease (2022)

●AHA: Scientific statement on genetic testing for inherited cardiovascular diseases (2020)

●American Academy of Pediatrics (AAP): Health supervision for children with Marfan syndrome (2013, reaffirmed 2019)

●AHA and ACC: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities – Aortic diseases, including Marfan syndrome (2015)

●American College of Medical Genetics (ACMG): Practice guidelines for evaluation of the adolescent or adult with some features of Marfan syndrome (2012)

●AHA: Scientific statement for surgical management of descending thoracic aortic disease – Open and endovascular approaches (2010)

Europe

●European Society of Cardiology (ESC): Guidelines for the management of cardiovascular diseases during pregnancy (2018)

●Society for Cardiovascular Pathology (SCVP) and the Association for European Cardiovascular Pathology (AECVP): Consensus statement on surgical pathology of the aorta – Noninflammatory degenerative diseases: Nomenclature and diagnostic criteria (2016)

●ESC: Clinical practice guidelines on the diagnosis and treatment of aortic diseases (2014)

●ESC: Clinical practice guidelines for the management of grown-up congenital heart disease (2010)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome (2022)

Australia–New Zealand

●Cardiac Society of Australia and New Zealand (CSANZ): Position statement update on the diagnosis and management of inherited aortopathies, including Marfan syndrome (2016)

Japan

●[In Japanese] Japanese Circulation Society (JCS)/Japanese Society of Cardiovascular Surgery (JSCS)/Japanese Association of Thoracic Surgery (JATS)/Japanese Society of Vascular Surgery (JSVS): Guideline on diagnosis and treatment of aortic aneurysm and aortic dissection (2020)